Polyol Pathway and Diabetic Nephropathy Revisited: Early Tubular Cell Changes and Glomerulopathy in Diabetic Mice Overexpressing Human Aldose Reductase

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2014 May 21

PMID 24843470

Citations 18

Authors

Yasuhiro Hashimoto

Shin-Ichiro Yamagishi

Hiroki Mizukami

Chihiro Yabe-Nishimura

Sun Woo Lim

H Moo Kwon

Soroku Yagihashi

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Aims/Introduction: The polyol pathway has long been involved in the pathogenesis of diabetic nephropathy. It remains still unclear, however, how the polyol pathway is implicated in this process. We explored the effects of the enhanced polyol pathway on renocortical tubular cells and glomeruli in experimentally-induced diabetes.

Materials And Methods: Transgenic mice (Tg) overexpressing human aldose reductase were made diabetic by streptozotocin and followed for 8 weeks. Renocortical pathology, expressions of tonicity-responsive enhancer binding protein (TonEBP) and carboxymethyllysine of advanced glycation end-products, were examined. Wild-type non-transgenic mice (Wt) were also made diabetic and served as controls.

Results: Diabetic Tg showed augmented expression of TonEBP in renocortical tubular cells with vacuolated degenerative changes. These structural changes were associated with pronounced deposition of carboxymethyllysine. There was a significant increase in kidney weight, glomerular size, and mesangial area in diabetic animals and there was a trend for more severe changes in these measures in diabetic transgenic mice compared with those in control diabetic mice. Treatment with aldose reductase inhibitor significantly prevented polyol accumulation, mesangial expansion and expressions of TonEBP and carboxymethyllysine in diabetic Tg, but its effects on the renal structure were equivocal in control diabetic Wt.

Conclusions: Our findings suggest that tubuloglomerular change might contribute to early diabetic nephropathy under the influence of the enhanced polyol pathway. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00071.x, 2010).

Citing Articles

Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions.

Jha R, Lopez-Trevino S, Kankanamalage H, Jha J Biomedicines. 2024; 12(5).

PMID: 38791060 PMC: 11118045. DOI: 10.3390/biomedicines12051098.

Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy.

Hu Q, Yang Q, Gao H, Tian J, Che G J Diabetes Investig. 2024; 15(5):572-583.

PMID: 38268239 PMC: 11060157. DOI: 10.1111/jdi.14144.

The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities.

Gupta J Curr Pharm Biotechnol. 2023; 25(9):1073-1081.

PMID: 37649296 DOI: 10.2174/1389201025666230830125147.

Predictive Effects of FT3/FT4 on Diabetic Kidney Disease: An Exploratory Study on Hospitalized Euthyroid Patients with T2DM in China.

Zhao X, Sun J, Xin S, Zhang X Biomedicines. 2023; 11(8).

PMID: 37626708 PMC: 10452238. DOI: 10.3390/biomedicines11082211.

Chemical Composition of the Leaf Essential Oil and Analysis of Its Antioxidant, Enzyme Inhibitory and Antibacterial Activities.

Kuttithodi A, Narayanankutty A, Visakh N, Job J, Pathrose B, Olatunji O Antibiotics (Basel). 2023; 12(5).

PMID: 37237843 PMC: 10215355. DOI: 10.3390/antibiotics12050940.

References

Thomas M, Burns W, Cooper M . Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis. 2005; 12(2):177-86. DOI: 10.1053/j.ackd.2005.01.008. View

Pedersen M, Christiansen J, Mogensen C . Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition. Diabetes. 1991; 40(5):527-31. DOI: 10.2337/diab.40.5.527. View

Larkins R, Dunlop M . The link between hyperglycaemia and diabetic nephropathy. Diabetologia. 1992; 35(6):499-504. DOI: 10.1007/BF00400475. View

Yamaoka T, Nishimura C, Yamashita K, Itakura M, Yamada T, Fujimoto J . Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia. 1995; 38(3):255-61. DOI: 10.1007/BF00400627. View

Hostetter T, Rennke H, Brenner B . The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med. 1982; 72(3):375-80. DOI: 10.1016/0002-9343(82)90490-9. View

Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K . Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia. 1998; 41(12):1426-34. DOI: 10.1007/s001250051088. View

Baynes J, Thorpe S . Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999; 48(1):1-9. DOI: 10.2337/diabetes.48.1.1. View

Nagai R, Unno Y, Hayashi M, Masuda S, Hayase F, Kinae N . Peroxynitrite induces formation of N( epsilon )-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes. 2002; 51(9):2833-9. DOI: 10.2337/diabetes.51.9.2833. View

Yagihashi N, Nishida N, Seo H, Taniguchi N, Yagihashi S . Expression of nitric oxide synthase in macula densa in streptozotocin diabetic rats. Diabetologia. 1996; 39(7):793-9. DOI: 10.1007/s001250050512. View

10.

Terubayashi H, Sato S, Nishimura C, Kador P, KINOSHITA J . Localization of aldose and aldehyde reductase in the kidney. Kidney Int. 1989; 36(5):843-51. DOI: 10.1038/ki.1989.270. View

11.

Cha J, Woo S, Han K, Kim Y, Handler J, Kim J . Hydration status affects nuclear distribution of transcription factor tonicity responsive enhancer binding protein in rat kidney. J Am Soc Nephrol. 2001; 12(11):2221-2230. DOI: 10.1681/ASN.V12112221. View

12.

Suzuki D, Miyata T, Saotome N, Horie K, Inagi R, Yasuda Y . Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol. 1999; 10(4):822-32. DOI: 10.1681/ASN.V104822. View

13.

Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H . Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest. 1998; 100(12):2995-3004. PMC: 508511. DOI: 10.1172/JCI119853. View

14.

Jensen E, Gundersen H, Osterby R . Determination of membrane thickness distribution from orthogonal intercepts. J Microsc. 1979; 115(1):19-33. DOI: 10.1111/j.1365-2818.1979.tb00149.x. View

15.

Williamson J, Chang K, Frangos M, Hasan K, Ido Y, Kawamura T . Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993; 42(6):801-13. DOI: 10.2337/diab.42.6.801. View

16.

Hwang Y, Kaneko M, Bakr S, Liao H, Lu Y, Lewis E . Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J. 2004; 18(11):1192-9. DOI: 10.1096/fj.03-1400com. View

17.

Koya D, King G . Protein kinase C activation and the development of diabetic complications. Diabetes. 1998; 47(6):859-66. DOI: 10.2337/diabetes.47.6.859. View

18.

Maeda S, Haneda M, Yasuda H, Tachikawa T, Isshiki K, Koya D . Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes. Diabetes. 1999; 48(2):420-2. DOI: 10.2337/diabetes.48.2.420. View

19.

Goldfarb S, Ziyadeh F, Kern E, Simmons D . Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats. Diabetes. 1991; 40(4):465-71. DOI: 10.2337/diab.40.4.465. View

20.

Tilton R, Chang K, Pugliese G, Eades D, Province M, Sherman W . Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes. 1989; 38(10):1258-70. DOI: 10.2337/diab.38.10.1258. View